Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Blackhawk Growth Corp
(OP:
BLRZF
)
0.0006
UNCHANGED
Last Price
Updated: 10:18 AM EDT, Oct 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Blackhawk Growth Corp
Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup
November 15, 2022
Colorado Voters Approve Initiative To Legalize And Regulate Psychedelics
Via
Benzinga
Psychedelics Investment Holder Blackhawk Growth Hosts Meeting For Potential Subsidiary Spin-Out
November 09, 2022
Blackhawk Growth Corp. (OTCMKTS: BLRZF), an investment holding company focused on acquiring and developing high-growth companies in the health, cannabis and psychedelics sectors in the US and Canada,...
Via
Benzinga
LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress
November 04, 2022
Holding company Blackhawk Growth Corp.(OTC: BLRZF)'s subsidiary company MindBio Therapeutics Pty Ltd shared the positive data gathered from its
Via
Benzinga
Recap: Blackhawk Growth Fund's Most Recent Business Highlights, From Retail Sales To Phase 2 Clinical Trials
August 10, 2022
Blackhawk Growth Corp.
Via
Benzinga
New Zealand Government Grants $650K For LSD Microdosing Trials
July 25, 2022
Mindbio Therapeutics, a subsidiary of cannabis and psychedelics holding company Blackhawk Growth Corp.
Via
Benzinga
Psyched: Protesters At DEA HQ Demand Access To Psychedelics, Connecticut Approves Budget Bill With MDMA & Psilocybin Programs
May 10, 2022
Psychedelics policy action took center stage this week.
Via
Benzinga
The World's Largest Microdosing Clinical Trial Has Been Completed, Here Are The Results
May 04, 2022
Mindbio Therapeutics, a company of the Blackhawk Growth Corp. (OTCPK: BLRZF) announced the completion of the world’s largest Phase 1 clinical trial for LSD microdosing...
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.